|
|
Reference
|
|
 
|
Agacayak, E., Tunc, S.Y., Sak, S., Basaranoglu, S., Yüksel, H., Turgut, A., Gul, T. (2015) Levels of neopterin and other inflammatory markers in obese and non-obese patients with polycystic ovary syndrome. Med Sci Monit, 21: 2446-55
|
|
|
Anderssohn, M., Schwedhelm, E., Lüneburg, N., Vasan, R.S., Böger, R.H. (2010) Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: An intriguing interaction with diabetes mellitus. Diabetes and Vascular Disease Research, 7(2): 105-118
|
|
|
Avcı, E., Coskun, C.S., Cakır, E., Yaman, H., Bilgi, C. (2014) Determination of oxidative stress and cellular immunity in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure. Renal Failure, 36 (5): 776-3
|
|
|
Avcı, E., Coşkun, Ş., Çakır, E., Kurt, Y., Akgül, E.Ö., Bilgi, C. (2008) Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients. Renal Failure, 30(8): 784-790
|
|
|
Barthelmes, J., Nägele, M.P., Ludovici, V., Ruschitzka, F., Sudano, I., Flammer, A.J. (2017) Endothelial dysfunction in cardiovascular disease and Flammer syndrome: Similarities and differences. EPMA Journal, 8(2): 99-109
|
|
|
Baskın, Y., Yiğitbaşı, T., Afacan, G., Bağbozan, Ş. (2008) İnsülin direnci olan erişkin kilolu ve obezlerde lipoprotein (a) ile lipid parametreleri. Türk Klinik Biyokimya Derg, 6(2): 65-71
|
|
|
Bekçi, T.T., Kesli, R., Koçak, N. (2010) Serum neopterin levels in obese and nonobese patients with obstructive sleep apnea syndrome. Journal of Inonu University Faculty of Medicine, 17(3): 165-8
|
|
|
Bhurosy, T., Jeewon, R. (2014) Overweight and obesity epidemic in developing countries: A problem with diet, physical activity, or socioeconomic status?. Scientific World Journal, 2014: 1-7, 964236
|
|
|
Dückelmann, C., Mittermayer, F., Haider, D.G., Altenberger, J., Eichinger, J., Wolzt, M. (2007) Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(9): 2037-2042
|
|
|
Eberhard, R. (2007) Total cardiovascular risk management. Am J Cardiol, 100: 53-60
|
|
|
Eid, H.M.A., Arnesen, H., Hjerkinn, E.M., Lyberg, T., Seljeflot, I. (2004) Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism, 53(12): 1574-1579
|
|
|
el Assar, M., Angulo, J., Santos-Ruiz, M., Ruiz, de A.J.C., Pindado, M.L., Sánchez-Ferrer, A.L., Hernández, A., Rodríguez-Mañas, L. (2016) Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans. Journal of Physiology, 594(11): 3045-3060
|
|
|
el Assar, M., Ruiz, de A.J.C., Angulo, J.C., Pindado, M.M.L., Hernández, M.A., Rodríguez-Mañas, L. (2013) Preserved endothelial function in human obesity in the absence of insulin resistance. Journal of Translational Medicine, 11(1): 263-263
|
|
|
Engin, A.B. (2017) Adipocyte-macrophage cross-talk in obesity. u: Adv. exp. med. biol: Obesity and lipotoxicity, 960: 327-343
|
|
|
Erdoğmuş, F., Koca, C., Selçoki, Y., Karakurt, F., Aydın, M., Çarlıoğlu, A., Eryonucu, B., Yiğitoğlu, R. (2009) Metabolik Sendromda Endotel Disfonksiyonu ve Ateroskleroz Riski Arasındaki İlişkinin Oksidatif Stres Üzerinden Değerlendirilmesi. Turkiye Klinikleri J Cardiovasc Sci, 21(1)
|
|
1
|
Grammer, T.B., Fuchs, D., Boehm, B.O., Winkelmann, B.R., Maerz, W. (2009) Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health Study. Clinical Chemistry, 55(6): 1135-1146
|
|
|
Hajar, R. (2016) Framingham contribution to cardiovascular disease. Heart Views, 17(2): 78-81
|
|
|
Huang, F., del-Río-Navarro Blanca, E., Pérez, O.J.A., Ruiz-Bedolla, E., Navarro-Olivos, E., Villafaña, S., Bravo, G., Hong, E. (2013) Changes in ghrelin and asymmetrical dimethylarginine in obese Mexican adolescents after six-month lifestyle intervention. Endocrine, 43(3): 603-610
|
|
|
Jackson, V. M., Breen, D.M., Fortin, J., Liou, A., Kuzmiski, J. B., Loomis, A. K., Rives, M., Shah, B., Carpino, P.A. (2015) Latest approaches for the treatment of obesity. Expert Opinion on Drug Discovery, 10(8): 825-839
|
|
|
Kabaroğlu, C., Ersoy, B., Onur, E., Özhan, B., Erdin, S., Var, A., Bayındır, O., Dinç, G. (2013) Elevated glucose level at 30 minutes during an oral glucose tolerance test in obese adolescents: A new disorder of glucose tolerance. Endocrine Journal, 60(2): 197-205
|
|
|
Kocak, H., Oner-Iyidogan, Y., Gurdol, F., Oner, P., Esin, D. (2011) Serum asymmetric dimethylarginine and nitric oxide levels in obese postmenopausal women. Journal of Clinical Laboratory Analysis, 25(3): 174-178
|
|
|
Koliaki, C., Liatis, S., Kokkinos, A. (2019) Obesity and cardiovascular disease: Revisiting an old relationship. Metabolism, 92: 98-107
|
|
1
|
Krzyzanowska, K., Mittermayer, F., Kopp, H., Wolzt, M., Schernthaner, G. (2004) Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. Journal of Clinical Endocrinology & Metabolism, 89(12): 6277-6281
|
|
|
Liu, X., Hou, L., Xu, D., Chen, A., Yang, L., Zhuang, Y., Xu, Y., Fassett, J.T., Chen, Y. (2016) Effect of asymmetric dimethylarginine (ADMA) on heart failure development. Nitric Oxide, 54: 73-81
|
|
|
Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G.A., Beguinot, F., Miele, C. (2019) Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. International Journal of Molecular Sciences, 20(9), pii: E2358
|
|
|
Mangge, H., Almer, G., Truschnig-Wilders, M., Schmidt, A., Gasser, R., Fuchs, D. (2010) Inflammation, adiponectin, obesity and cardiovascular risk. Current Medicinal Chemistry, 17(36): 4511-4520
|
|
|
Mangge, H., Freytag, F., Almer, G., Weghuber, D., Bauer-Denk, C., Fuchs, D. (2011) Serum neopterin is not increased in obese juveniles. Journal of Obesity, 2011: 1-7, 946795
|
|
1
|
Marliss, E.B., Chevalier, S., Gougeon, R., Morais, J.A., Lamarche, M., Adegoke, O.A.J., Wu, G. (2006) Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover. Diabetologia, 49(2): 351-359
|
|
|
Mathieu, P., Poirier, P., Pibarot, P., Lemieux, I., Després, J.P. (2009) Visceral obesity: The link among inflammation, hypertension, and cardiovascular disease. Hypertension, 53(4): 577-84
|
|
1
|
Matsubara, M., Maruoka, S., Katayose, S. (2002) Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. European Journal of Endocrinology, 147(2): 173-180
|
|
|
Mclaughlin, T., Stühlinger, M., Lamendola, C., Abbasi, F., Bialek, J., Reaven, G.M., Tsao, P.S. (2006) Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. Journal of Clinical Endocrinology & Metabolism, 91(5): 1896-1900
|
|
|
Nageswara, R.G.S., Gurumurthy, P.E.S., Cherian, K.M. (2013) The clinical and biochemical parameters in relation to the serum neopterin levels in Indian children and adolescents. J Clin Diagn Res, 7(4): 618-21
|
|
|
Nakhjavani, M., Karimi-Jafari, H., Esteghamati, A., Khalilzadeh, O., Asgarani, F., Ghadiri-Anari, A. (2010) ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity. Annales d'Endocrinologie, Paris, 71(4): 303-308
|
|
|
Oishi, J.C., Castro, C.A., Silva, K.A., Fabricio, V., Cárnio, E.C., Phillips, S.A., Duarte, A.C.G.de O., Rodrigues, G.J. (2018) Endothelial dysfunction and inflammation precedes elevations in blood pressure induced by a high-fat diet. Arquivos Brasileiros de Cardiologia, 110(6): 558-67
|
|
|
Poobalan, A., Aucott, L. (2016) Obesity among young adults in developing countries: A systematic overview. Current Obesity Reports, 5(1): 2-13
|
|
|
Prieto, D., Contreras, C., Sanchez, A. (2014) Endothelial dysfunction, obesity and insulin resistance. Current Vascular Pharmacology, 12(3): 412-426
|
|
|
Şentürk, B.A., Üstüner, F., Aksu, S., Sülek, Z. (2005) Plasminojen Aktivatör Ünhibitör Tip I, İnsülin Direnci ve Android Obezite. Türk Klinik Biyokimya Derg, 3(3):109-15
|
|
|
Shuldiner, A.R., Yang, R., Gong, D. (2001) Resistin, obesity, and insulin resistance: The emerging role of the adipocyte as an endocrine organ. New England Journal of Medicine, 345(18): 1345-1346
|
|
|
Spencer, M.E., Jain, A., Matteini, A., Beamer, B.A., Wang, N.-Y., Leng, S.X., Punjabi, N.M., Walston, J.D., Fedarko, N.S. (2010) Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 65A(8): 858-865
|
|
|
Ursavaş, A., Karadag, M., Oral, A.Y., Demirdogen, E., Oral, H.B., Ege, E. (2008) Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respiratory Medicine, 102(8): 1193-1197
|
|
|
Yuniarty, D., Santoso, A., Arif, M. (2011) Correlation of neopterin and TNF-alpha with asymmetric dimethylarginine in metabolic syndrome. Indonesian Biomedical Journal, 3(3): 200-203
|
|
|
|
|